Segall Bryant & Hamill LLC Purchases Shares of 3,635 LivaNova PLC (LIVN)

Segall Bryant & Hamill LLC purchased a new position in shares of LivaNova PLC (NASDAQ:LIVN) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,635 shares of the company’s stock, valued at approximately $291,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its holdings in LivaNova by 3.2% during the fourth quarter. BlackRock Inc. now owns 4,796,615 shares of the company’s stock worth $383,345,000 after purchasing an additional 149,678 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in LivaNova by 42.9% in the third quarter. Dimensional Fund Advisors LP now owns 1,317,901 shares of the company’s stock valued at $92,331,000 after acquiring an additional 395,672 shares during the last quarter. Vaughan Nelson Investment Management L.P. purchased a new position in LivaNova in the fourth quarter valued at about $55,467,000. Bank of New York Mellon Corp boosted its stake in LivaNova by 0.5% in the third quarter. Bank of New York Mellon Corp now owns 532,698 shares of the company’s stock valued at $37,321,000 after acquiring an additional 2,470 shares during the last quarter. Finally, NWQ Investment Management Company LLC boosted its stake in LivaNova by 71.2% in the third quarter. NWQ Investment Management Company LLC now owns 500,594 shares of the company’s stock valued at $35,072,000 after acquiring an additional 208,264 shares during the last quarter. Institutional investors and hedge funds own 85.52% of the company’s stock.

In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $83.32, for a total value of $83,320.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider David S. Wise sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $88.17, for a total transaction of $132,255.00. The disclosure for this sale can be found here. In the last three months, insiders sold 4,500 shares of company stock worth $386,035. Insiders own 0.28% of the company’s stock.

LivaNova PLC (NASDAQ LIVN) opened at $84.24 on Monday. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.14 and a quick ratio of 1.79. The firm has a market cap of $4,068.47, a PE ratio of -156.00, a price-to-earnings-growth ratio of 2.63 and a beta of 0.75. LivaNova PLC has a 52 week low of $48.58 and a 52 week high of $92.31.

LivaNova (NASDAQ:LIVN) last released its earnings results on Wednesday, February 28th. The company reported $0.88 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.10. LivaNova had a negative net margin of 2.10% and a positive return on equity of 9.37%. The firm had revenue of $278.40 million for the quarter, compared to analysts’ expectations of $278.48 million. During the same period in the previous year, the company earned $0.83 earnings per share. The company’s quarterly revenue was up 11.5% on a year-over-year basis. equities research analysts anticipate that LivaNova PLC will post 3.2 EPS for the current year.

A number of research analysts have weighed in on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $104.00 target price (up from $97.00) on shares of LivaNova in a research note on Wednesday, February 28th. BidaskClub cut shares of LivaNova from a “buy” rating to a “hold” rating in a research note on Thursday, January 18th. Zacks Investment Research cut shares of LivaNova from a “buy” rating to a “hold” rating in a research note on Thursday, December 21st. ValuEngine upgraded shares of LivaNova from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, Canaccord Genuity reiterated a “hold” rating and issued a $76.00 target price on shares of LivaNova in a research note on Tuesday, December 5th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company. LivaNova has a consensus rating of “Hold” and a consensus target price of $81.43.

ILLEGAL ACTIVITY WARNING: This article was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/3302430/segall-bryant-hamill-llc-purchases-shares-of-3635-livanova-plc-livn.html.

About LivaNova

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Institutional Ownership by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Four Corners Property  Releases  Earnings Results, Misses Expectations By $0.09 EPS
Four Corners Property Releases Earnings Results, Misses Expectations By $0.09 EPS
WestRock  Given News Impact Score of 0.27
WestRock Given News Impact Score of 0.27
Mylan  Receiving Somewhat Favorable Media Coverage, Analysis Shows
Mylan Receiving Somewhat Favorable Media Coverage, Analysis Shows
Global Payments  Given News Sentiment Score of 0.14
Global Payments Given News Sentiment Score of 0.14
Bitvolt Price Reaches $0.0013 on Exchanges
Bitvolt Price Reaches $0.0013 on Exchanges
Tandem Diabetes Care  Posts Quarterly  Earnings Results, Misses Estimates By $1.38 EPS
Tandem Diabetes Care Posts Quarterly Earnings Results, Misses Estimates By $1.38 EPS


© 2006-2018 Ticker Report. Google+.